Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | (+)-JQ1 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2716 | 398 | 0.1639 | 0.1471 | 0.1465 | 0.1569 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1783 | 632 | 0.1644 | 0.1453 | 0.3545 | 0.3955 |
A-375 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 3 | 2535 | 255 | 0.1648 | 0.1801 | 0.1006 | 0.0950 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3381 | 232 | 0.1648 | 0.1538 | 0.0686 | 0.0753 |
COLO 858 | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 1 | 1325 | 410 | 0.1650 | 0.1528 | 0.3094 | 0.2918 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 454 | 186 | 0.1651 | 0.1742 | 0.4097 | 0.4178 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3477 | 209 | 0.1655 | 0.1621 | 0.0601 | 0.0672 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 3 | 2847 | 209 | 0.1659 | 0.1658 | 0.0734 | 0.0732 |
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 3 | 2810 | 172 | 0.1659 | 0.1694 | 0.0612 | 0.0638 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 592 | 82 | 0.1663 | 0.3290 | 0.1385 | 0.1295 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1241 | 575 | 0.1663 | 0.1470 | 0.4633 | 0.4830 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 3269 | 84 | 0.1667 | 0.1598 | 0.0257 | 0.0325 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 3302 | 117 | 0.1667 | 0.1598 | 0.0354 | 0.0325 |
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 2 | 2861 | 198 | 0.1675 | 0.1694 | 0.0692 | 0.0638 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 3389 | 65 | 0.1683 | 0.1709 | 0.0192 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 3598 | 270 | 0.1685 | 0.1621 | 0.0750 | 0.0672 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 443 | 169 | 0.1688 | 0.2245 | 0.3815 | 0.3979 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3676 | 151 | 0.1689 | 0.1741 | 0.0411 | 0.0433 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 1844 | 660 | 0.1691 | 0.1486 | 0.3579 | 0.3478 |
A-375 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2660 | 263 | 0.1695 | 0.2108 | 0.0989 | 0.0957 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3458 | 92 | 0.1704 | 0.1709 | 0.0266 | 0.0246 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 1488 | 457 | 0.1710 | 0.1736 | 0.3071 | 0.3188 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 1562 | 528 | 0.1715 | 0.1736 | 0.3380 | 0.3188 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 2962 | 234 | 0.1716 | 0.1658 | 0.0790 | 0.0732 |